PCT/2001/21 : PCT Gazette, Weekly Issue No. 21, 2001 - WIPO
PCT/2001/21 : PCT Gazette, Weekly Issue No. 21, 2001 - WIPO
PCT/2001/21 : PCT Gazette, Weekly Issue No. 21, 2001 - WIPO
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>21</strong>/<strong>2001</strong><br />
8620 <strong>PCT</strong> <strong>Gazette</strong> - Section I - <strong>Gazette</strong> du <strong>PCT</strong> 25 May/mai <strong>2001</strong><br />
SK SL TJ TM TR TT TZ UA UG US UZ VN<br />
YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 A61K 38/00<br />
(11) WO 01/35979 (13) A2<br />
(<strong>21</strong>) <strong>PCT</strong>/US00/4<strong>21</strong>37<br />
(22) 13 <strong>No</strong>v/nov 2000 (13.11.2000)<br />
(25) en (26) en<br />
(30) 60/165,418 13 <strong>No</strong>v/nov 1999 US<br />
(13.11.1999)<br />
(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />
(54) COMBINED PDE3 AND PDE4 IN-<br />
HIBITOR THERAPY FOR THE TREAT-<br />
MENT OF OBESITY<br />
THERAPIE COMBINANT DES INHIBI-<br />
TEURS DE PDE3 ET DE PDE4 POUR LE<br />
TRAITEMENT DE L’OBESITE<br />
(71) ICOS CORPORATION [US/US]; 220<strong>21</strong><br />
20th Avenue, S.E., Bothell, WA 980<strong>21</strong> (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) SNYDER, Peter [US/US]; 6015 36th<br />
Avenue, N.E., Seattle, WA 98115 (US).<br />
(74) GASS, David, A.; Marshall, O’Toole, Gerstein,<br />
Murray & Borun, 6300 Sears Tower,<br />
233 S. Wacker Drive, Chicago, IL 60606<br />
(US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CR CU CZ DE DK DM<br />
DZ EE ES FI GB GD GE GH GM HR HU<br />
ID IL IN IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW<br />
MX MZ NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ VN<br />
YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 A61K 38/04, 39/395, G01N 33/53, 33/567,<br />
C12N 5/12<br />
(11) WO 01/35980<br />
(<strong>21</strong>) <strong>PCT</strong>/US00/31051<br />
(13) A1<br />
(22) 14 <strong>No</strong>v/nov 2000 (14.11.2000)<br />
(25) en (26) en<br />
(30) 09/439,690 14 <strong>No</strong>v/nov 1999<br />
(14.11.1999)<br />
US<br />
(30) 09/684,813 10 Oct/oct 2000<br />
(10.10.2000)<br />
US<br />
(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />
(54) HUMAN IgM ANTIBODIES TO<br />
CHEMOKINE RECEPTORS<br />
ANTICORPS IgM HUMAINS CONTRE<br />
LES RECEPTEURS DE CHIMIOKINE<br />
(71) MONICAID CORPORATION [US/US];<br />
348 Keywest Drive, Charlottesville, VA<br />
22911 (US).<br />
(72) LOBO, Peter, I.; 348 Keywest Drive, Charlottesville,<br />
VA 22911 (US).<br />
(74) KELBER, Steven, B. et al. / etc.; Piper Marbury<br />
Rudnick & Wolfe LLP, 1200 Nineteenth<br />
Street, N.W., Washington, DC 20036-2412<br />
(US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CR CU CZ DE DK DM<br />
DZ EE ES FI GB GD GE GH GM HR HU<br />
ID IL IN IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW<br />
MX MZ NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG UZ VN YU<br />
ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
Published / Publiée :(c)<br />
(51) 7 A61K 38/04, 38/10, 38/17, C07K 7/08<br />
(11) WO 01/35981 (13) A1<br />
(<strong>21</strong>) <strong>PCT</strong>/US00/317<strong>21</strong><br />
(22) 20 <strong>No</strong>v/nov 2000 (20.11.2000)<br />
(25) en (26) en<br />
(30) 60/166,600 19 <strong>No</strong>v/nov 1999 US<br />
(19.11.1999)<br />
(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />
(54) METHODS AND COMPOSITIONS FOR<br />
TREATMENT OF DISEASE<br />
METHODES ET COMPOSITIONS DE<br />
TRAITEMENT DE MALADIES<br />
(71) ADVANCED MICROBIAL SOLUTIONS<br />
CORPORATION [US/US]; 100 Inman<br />
Street, Cambridge, MA 0<strong>21</strong>39 (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) MURPHY, John, R. [US/US]; 130<br />
Appleton Street, Boston, MA 0<strong>21</strong>16 (US).<br />
HARRISON, Robert, J. [US/US]; 31 Green<br />
Street, Medfield, MA 02052 (US).<br />
(74) FOLEY, Shawn, P. et al. / etc.; Lerner,<br />
David, Littenberg, Krumholz & Mentlik, LLP,<br />
600 South Avenue West, Westfield, NJ 07090-<br />
1497 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CR CU CZ DE DK DM<br />
DZ EE ES FI GB GD GE GH GM HR HU<br />
ID IL IN IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW<br />
MX MZ NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ VN<br />
YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
Published / Publiée :(c)<br />
(51) 7 A61K 38/05<br />
(11) WO 01/35982 (13) A1<br />
(<strong>21</strong>) <strong>PCT</strong>/JP99/06353<br />
(22) 12 <strong>No</strong>v/nov 1999 (12.11.1999)<br />
(25) ja (26) ja<br />
(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />
(54) ANTIINFLAMMATORY MEDICINAL<br />
COMPOSITIONS<br />
COMPOSITIONS MEDICINALES<br />
ANTI-INFLAMMATOIRES<br />
(71) FUJIMOTO BROTHERS CO., LTD.<br />
[JP/JP]; 3-40, Nishiotsuka 1-chome, Matsubara-shi,<br />
Osaka 580-0011 (JP). LEK TO-<br />
VARNA FARMACEVTSKIH IN KEMIC-<br />
NIH IZDELKOV D.D. [SI/SI]; Verovskova<br />
57, 1526 Ljubljana (SI).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) YONEDA, Fumio [JP/JP]; Fujimoto<br />
Pharmaceutical Co., Ltd., 3-40, Nishiotsuka<br />
1-chome, Matsbara-shi, Osaka 580-0011 (JP).<br />
MURAOKA, Shizuko [JP/JP]; Fujimoto<br />
Pharmaceutical Co., Ltd., 3-40, Nishiotsuka<br />
1-chome, Matsubara-shi, Osaka 580-0011<br />
(JP). MORIGICHI, Miho [JP/JP]; Fujimoto<br />
Pharmaceutical Co., Ltd., 3-40, Nishiotsuka<br />
1-chome, Matsubara-shi, Osaka 580-0011<br />
(JP). NORISADA, <strong>No</strong>buyoshi [JP/JP];<br />
Fujimoto Pharmaceutical Co., Ltd., 3-40,<br />
Nishiotsuka 1-chome, Matsubara-shi, Osaka<br />
580-0011 (JP). OCHI, Chizuru [JP/JP];<br />
Fujimoto Pharmaceutical Co., Ltd., 3-40,<br />
Nishiotsuka 1-chome, Matsubara-shi, Osaka<br />
580-0011 (JP). STALC, Anton [SI/SI];<br />
Rasiska 5, 1000 Ljubljana (SI). LAVRIC,<br />
Anton [SI/SI]; Pijava Gorica 206, 1291<br />
Pijava Gorica (SI). URLEB, Uros [SI/SI];<br />
Herbersteinova 18, 1000 Ljubljana (SI).<br />
(74) FUJIMOTO BROTHERS CO., LTD.;<br />
3-40, Nishiotsuka 1-chome, Matubara-shi,<br />
Osaka 580-0011 (JP).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA<br />
CH CN CU CZ DE DK EE ES FI GB GD GE<br />
GH GM HR HU ID IL IN IS KE KG KP KR<br />
KZ LC LK LR LS LT LU LV MD MG MK<br />
MN MW MX NO NZ PL PT RO RU SD SE<br />
SG SI SK SL TJ TM TR TT UA UG US UZ<br />
VN YU ZW.<br />
(84) AP (GH GM KE LS MW SD SL SZ TZ UG<br />
ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF<br />
BJ CF CG CI CM GA GN GW ML MR NE<br />
SN TD TG).<br />
(51) 7 A61K 38/06, 38/05, 31/198<br />
(11) WO 01/35983 (13) A1<br />
(<strong>21</strong>) <strong>PCT</strong>/SE00/02241<br />
(22) 15 <strong>No</strong>v/nov 2000 (15.11.2000)<br />
(25) en (26) en<br />
(30) 9904132-9 16 <strong>No</strong>v/nov 1999 SE<br />
(16.11.1999)<br />
(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />
(54) PHARMACEUTICAL COMPOSITION<br />
FOR TREATMENT OF DIARRHEA<br />
COMPOSITION PHARMACEUTIQUE<br />
DE TRAITEMENT DE LA DIARRHEE<br />
(71) KAROLINSKA INNOVATIONS AB<br />
[SE/SE]; Tomtebodavägen 11, F, S-171 77<br />
Stockholm (SE).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) BURMAN, Lars, G. [SE/SE]; Södermannagatan<br />
64A, S-116 65 Stockholm (SE).<br />
KARLSSON, Sture [SE/SE]; Poppelvägen<br />
7, S-191 41 Sollentuna (SE). ÅKERLUND,